 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/17/2024 |
$0.68 |
$0.73 |
$0.68 |
$0.71 |
832.60K | | 04/18/2024 |
$0.72 |
$0.74 |
$0.69 |
$0.69 |
830.30K | | 04/19/2024 |
$0.69 |
$0.71 |
$0.64 |
$0.66 |
1.63M | | 04/22/2024 |
$0.67 |
$0.70 |
$0.66 |
$0.70 |
856.90K | | 04/23/2024 |
$0.69 |
$0.72 |
$0.67 |
$0.72 |
833.20K |
|
|
| Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease. | |
|
Atara Biotherapeutics (ATRA) has the following price history information. Looking back at ATRA historical stock prices for the last five trading days, on April 17, 2024, ATRA opened at $0.68, traded as high as $0.73 and as low as $0.68, and closed at $0.71. Trading volume was a total of 832.60K shares. On April 18, 2024, ATRA opened at $0.72, traded as high as $0.74 and as low as $0.69, and closed at $0.69. Trading volume was a total of 830.30K shares. On April 19, 2024, ATRA opened at $0.69, traded as high as $0.71 and as low as $0.64, and closed at $0.66. Trading volume was a total of 1.63M shares. On April 22, 2024, ATRA opened at $0.67, traded as high as $0.70 and as low as $0.66, and closed at $0.70. Trading volume was a total of 856.90K shares. On April 23, 2024, ATRA opened at $0.69, traded as high as $0.72 and as low as $0.67, and closed at $0.72. Trading volume was a total of 833.20K shares.
ATRA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Atara Biotherapeutics shares, starting with a $10,000 purchase of ATRA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/17/2014 |
|
| End date: |
04/23/2024 |
|
| Start price/share: |
$12.00 |
|
| End price/share: |
$0.72 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-94.01% |
|
| Average Annual Total Return: |
-25.59% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$599.11 |
|
| Years: |
9.52 |
|
|
|
| Date |
Close |
| 04/17/2024 | $0.71 | | 04/18/2024 | $0.69 | | 04/19/2024 | $0.66 | | 04/22/2024 | $0.70 | | 04/23/2024 | $0.72 |
|
|
Free ATRA Email Alerts:
